Can Progesterone Cause Tremors?
Yes, progesterone and progestins can cause tremors, though this is not a commonly reported adverse effect in standard obstetric use. The evidence for tremor as a side effect comes primarily from high-dose progestin therapy rather than the doses typically used in pregnancy management.
Evidence from FDA Drug Labeling and Clinical Studies
The FDA-approved prescribing information for oral progesterone does not list tremor as a common adverse reaction in the standard dosing used for postmenopausal women or pregnancy support 1. In controlled trials of progesterone capsules at doses of 200-400 mg daily, tremor was not among the adverse reactions reported in ≥2% of patients 1.
High-Dose Progestin Context
Tremor becomes clinically relevant with high-dose progestin therapy, particularly medroxyprogesterone acetate (MPA). Studies of MPA at doses of 500 mg/day or higher—used in cancer treatment—list tremor as one of the common adverse events 2. At these suprapharmacologic doses:
- Tremor occurs alongside other glucocorticoid-like effects (weight gain, moon face, muscle cramps)
- Up to 30% of patients develop glucocorticoid-like effects when treated for >6 weeks
- Cushing's syndrome has been documented even at 400 mg/day 2
Neurological Effects and Mechanisms
Research on neuroactive steroid alterations provides mechanistic insight. In patients with altered progesterone metabolism, neurological symptoms including tremors, muscular stiffness, and cramps have been reported alongside changes in cerebrospinal fluid levels of progesterone metabolites 3. This suggests progesterone's effects on the central nervous system can manifest as movement disorders under certain conditions.
Important Clinical Context
For standard obstetric progesterone use (17-hydroxyprogesterone caproate 250 mg IM weekly or vaginal progesterone 90-200 mg daily), tremor is not an expected or commonly reported side effect 4. These guidelines extensively review safety data and do not identify tremor as a concern at therapeutic doses for preterm birth prevention.
Key Caveats
- Dose-dependent effect: Tremor risk appears related to very high doses (≥400-500 mg/day), far exceeding standard pregnancy-related dosing
- Drug formulation matters: The tremor reports primarily involve synthetic progestins (MPA, megestrol acetate) rather than natural progesterone or 17-OHPC
- Individual susceptibility: Some patients may experience neurological effects at lower doses, particularly if progesterone metabolism is altered
- Differential diagnosis: If tremor develops during progesterone therapy, consider other causes including thyroid dysfunction, anxiety, or medication interactions
If a patient on standard-dose progesterone develops tremor, this warrants clinical evaluation for alternative etiologies rather than automatic attribution to progesterone.